Eli Lilly promises 40% discount for Innovent’s PD-1 in last-ditch bid to shift FDA review to drug pricing
Eli Lilly promises 40% discount for Innovent’s PD-1 in last-ditch [...]
Eli Lilly promises 40% discount for Innovent’s PD-1 in last-ditch [...]
FDA nominee Califf pledges to enforce accelerated approval mandates as [...]
AstraZeneca’s COVID vaccine sales reached $4B last year, but don’t [...]
GlaxoSmithKline’s COVID-19 antibody delivers as Nucala, Trelegy eclipse £1B landmark [...]
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics [...]
Roche pharma CEO Anderson talks up Vabysmo’s ‘very strong launch’ [...]
Eli Lilly, Innovent’s PD-1 in troubled waters as FDA review, [...]
As Pfizer reaps megablockbuster COVID-19 sales, CEO doesn’t see virus [...]
Teva forks over $150M to settle Texas opioid suit fkansteiner [...]
J&J, plowing ahead with talc bankruptcy strategy, faces investor push [...]